Youcare Pharmaceutical Group Co., Ltd.
As of 20 November 2026, for the company name Youcare Pharmaceutical Group Co., Ltd. as recorded, 3 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 65 records, across 47 drug names; since 23 August 2026, the records list Accepted: 2 applications, No longer listed under review: 2 applications, Supplement delivery: 2 applications (NMPA data as of 19 November 2026); the chemical-drug catalogue lists 39 active records with this name as holder; 5 further acceptance records name it after the first applicant.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.
Drug filings
65 acceptance records as first applicant, grouped into 47 source drug names. Source data as of 2026/11/20.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
枸橼酸爱地那非片 · No verified English name 5 records · Latest accepted 2026/09/20
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601766 | Supplement | 2026/09/20 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2601765 | Supplement | 2026/09/20 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2500736 | Supplement | 2025/04/12 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2201948 | Supplement | 2022/10/22 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHB2101000 | Supplement | 2021/03/12 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
灯盏花素片 · No verified English name 2 records · Latest accepted 2026/06/16
Supplement · 2
通脉降脂颗粒 · No verified English name 1 records · Latest accepted 2026/06/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2602709 | Supplement | 2026/06/16 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
四物胶囊 · No verified English name 2 records · Latest accepted 2026/05/18
Supplement · 2
YKYY017雾化吸入剂 · No verified English name 2 records · Latest accepted 2026/05/14
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600574 | New drug | 2026/05/14 | Youcare Pharmaceutical Group Co., Ltd.; Zhongguo Yi Xue Ke College Bing Yuan Bio Xue Research Institute romanized | CDE ↗ |
| CXHL2600573 | New drug | 2026/05/14 | Youcare Pharmaceutical Group Co., Ltd.; Zhongguo Yi Xue Ke College Bing Yuan Bio Xue Research Institute romanized | CDE ↗ |
Rosuvastatin Calcium Tablets 1 records · Latest accepted 2026/04/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600798 | Generic | 2026/04/08 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Aspirin Enteric-coated Tablets 1 records · Latest accepted 2025/11/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504036 | Generic | 2025/11/22 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Ceftazidime for Injection 1 records · Latest accepted 2025/11/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502285 | Supplement | 2025/11/05 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
注射用炎琥宁 · No verified English name 1 records · Latest accepted 2025/11/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502259 | Supplement | 2025/11/01 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
百蕊提取物 · No verified English name 2 records · Latest accepted 2025/10/14
New drug · 2
百蕊提取物颗粒 · No verified English name 2 records · Latest accepted 2025/10/14
New drug · 2
银杏叶提取物注射液 · No verified English name 1 records · Latest accepted 2025/03/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500574 | Supplement | 2025/03/20 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Azithromycin Capsules 1 records · Latest accepted 2025/01/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500436 | Generic | 2025/01/23 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Cefalexin Tablets 1 records · Latest accepted 2025/01/03
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550008 | Supplement | 2025/01/03 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Metformin Hydrochloride Extended-release Tablets 2 records · Latest accepted 2024/12/17
Supplement · 2
Oxacillin Sodium for Injection 2 records · Latest accepted 2024/10/24
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450534 | Supplement | 2024/10/24 | Youcare Pharmaceutical Group Co., Ltd.; Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2450533 | Supplement | 2024/10/24 | Youcare Pharmaceutical Group Co., Ltd.; Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Voriconazole for Injection 1 records · Latest accepted 2024/10/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403514 | Generic | 2024/10/17 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Sodium Valproate Concentrated Solution for Injection 1 records · Latest accepted 2024/09/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403302 | Generic | 2024/09/30 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Vonoprazan Fumarate Tablets 1 records · Latest accepted 2024/08/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402733 | Generic | 2024/08/22 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Dapagliflozin Tablets 1 records · Latest accepted 2024/07/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402365 | Generic | 2024/07/26 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Biapenem For Injection 1 records · Latest accepted 2024/07/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402162 | Generic | 2024/07/12 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Dapoxetine Hydrochloride Tablets 2 records · Latest accepted 2024/07/05
Generic · 2
二甲双胍维格列汀片(II) · No verified English name 1 records · Latest accepted 2024/06/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401801 | Generic | 2024/06/14 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Ganciclovir For Injection 2 records · Latest accepted 2024/04/12
Supplement · 2
Glimepiride Tablets 1 records · Latest accepted 2024/02/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450084 | Supplement | 2024/02/01 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Cefprozil Tablets 1 records · Latest accepted 2024/01/19
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450055 | Supplement | 2024/01/19 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
注射用羟基红花黄色素A · No verified English name 1 records · Latest accepted 2023/12/19
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZS2300027 | New drug | 2023/12/19 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
维生素C咀嚼片 · No verified English name 1 records · Latest accepted 2023/07/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301657 | Supplement | 2023/07/25 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
头孢拉定胶囊 · No verified English name 1 records · Latest accepted 2023/06/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350497 | Supplement | 2023/06/15 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Cefminox Sodium for Injection 1 records · Latest accepted 2023/05/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350447 | Supplement | 2023/05/18 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Cefmetazole Sodium for Injection 1 records · Latest accepted 2023/05/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350436 | Supplement | 2023/05/11 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
复方氨酚烷胺胶囊 · No verified English name 1 records · Latest accepted 2023/01/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300163 | Supplement | 2023/01/29 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Cefoxitin Sodium for Injection 1 records · Latest accepted 2023/01/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350064 | Supplement | 2023/01/14 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Omeprazole Enteric Capsules 1 records · Latest accepted 2023/01/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300075 | Supplement | 2023/01/11 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Cefazolin Sodium for Injection 2 records · Latest accepted 2023/01/05
Supplement · 2
Cefotaxime Sodium For Injection 1 records · Latest accepted 2022/10/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250646 | Supplement | 2022/10/18 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Esomeprazole Sodium for Injection 1 records · Latest accepted 2022/09/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201515 | Generic | 2022/09/14 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Rivaroxaban Tablets 1 records · Latest accepted 2022/07/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201123 | Generic | 2022/07/22 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Cefuroxime Sodium for Injection 2 records · Latest accepted 2022/03/22
Supplement · 2
Cefoperazone Sodium and Sulbactam Sodium for Injection 1 records · Latest accepted 2022/02/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250108 | Supplement | 2022/02/11 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Omeprazole Sodium for Injection 3 records · Latest accepted 2022/01/17
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250039 | Supplement | 2022/01/17 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2250038 | Supplement | 2022/01/17 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2150647 | Supplement | 2021/06/10 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
银杏叶片 · No verified English name 1 records · Latest accepted 2021/09/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2101656 | Supplement | 2021/09/13 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Azithromycin For Injection 1 records · Latest accepted 2021/08/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150791 | Supplement | 2021/08/09 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
阿司匹林咀嚼片 · No verified English name 1 records · Latest accepted 2021/03/26
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHT1600002 | Supplement | 2021/03/26 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Salbutamol Tablets 1 records · Latest accepted 2021/03/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHT1600010 | Supplement | 2021/03/10 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Lansoprazole For Injection 1 records · Latest accepted 2021/03/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150130 | Supplement | 2021/03/02 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
注射用盐酸头孢吡肟 · No verified English name 2 records · Latest accepted 2021/03/02
Supplement · 2
Changes in the last 90 days
6 events from 2026/08/23 to 2026/11/20. CDE data as of 2026/11/20; NMPA data as of 2026/11/19.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 2 applicationsNo longer listed under review: 2 applicationsSupplement delivery: 2 applications
- 2026/10/23No longer listed under review
枸橼酸爱地那非片 · No verified English name
CYHB2601766
Fact date: 2026/10/23 · Date added to this site: 2026/10/23
Accepted: 2026/09/20
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/10/23 (approval no.: —; approval date: 2026/10/21); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 23
NMPA · Table row 23 ↗ View source ↗ - 2026/10/23No longer listed under review
枸橼酸爱地那非片 · No verified English name
CYHB2601765
Fact date: 2026/10/23 · Date added to this site: 2026/10/23
Accepted: 2026/09/20
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/10/23 (approval no.: —; approval date: 2026/10/21); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 22
NMPA · Table row 22 ↗ View source ↗ - 2026/10/21Supplement delivery
枸橼酸爱地那非片 · No verified English name
CYHB2601766
Fact date: 2026/10/21 · Publication date: 2026/10/23 · Date added to this site: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 23 ↗ - 2026/10/21Supplement delivery
枸橼酸爱地那非片 · No verified English name
CYHB2601765
Fact date: 2026/10/21 · Publication date: 2026/10/23 · Date added to this site: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 22 ↗ - 2026/09/20Accepted
枸橼酸爱地那非片 · No verified English name
CYHB2601766
Fact date: 2026/09/20 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/20Accepted
枸橼酸爱地那非片 · No verified English name
CYHB2601765
Fact date: 2026/09/20 · Date added to this site: 2026/10/22
View source ↗
Under review
3 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Rosuvastatin Calcium Tablets | CYHS2600798 | Generic | 2026/04/08 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Aspirin Enteric-coated Tablets | CYHS2504036 | Generic | 2025/11/22 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 注射用羟基红花黄色素A · No verified English name | CXZS2300027 | New drug | 2023/12/19 | Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
Catalogue holder records
39 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | NMPA approval no. | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Cefalexin Tablets | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H11020097 | 2026/05/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Azithromycin Capsules | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20264464 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Voriconazole for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20263766 | 2026/03/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oxacillin Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H20103608 | 2026/01/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Oxacillin Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H20269027 | 2026/01/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Vonoprazan Fumarate Tablets | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20256450 | 2025/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 二甲双胍维格列汀片(II) · No verified English name | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20256257 | 2025/12/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Biapenem For Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20256081 | 2025/11/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapoxetine Hydrochloride Tablets | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20255898 | 2025/11/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapoxetine Hydrochloride Tablets | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20255899 | 2025/11/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20255613 | 2025/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ganciclovir For Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20053671 | 2025/04/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ganciclovir For Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20258058 | 2025/04/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Glimepiride Tablets | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20194036 | 2024/12/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefprozil Tablets | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20184107 | 2024/11/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefmetazole Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20123348 | 2024/10/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 头孢拉定胶囊 · No verified English name | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H11020106 | 2024/07/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefminox Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20213712 | 2024/05/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoxitin Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20103787 | 2024/05/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Esomeprazole Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20243392 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefazolin Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20045016 | 2024/01/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefazolin Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20045015 | 2024/01/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rivaroxaban Tablets | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20234527 | 2023/11/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefotaxime Sodium For Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20043012 | 2023/10/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20043010 | 2023/07/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefuroxime Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20063759 | 2023/04/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefuroxime Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20063758 | 2023/04/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Omeprazole Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20063740 | 2023/03/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Omeprazole Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20093941 | 2023/03/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Omeprazole Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20059354 | 2022/09/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Azithromycin For Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20094017 | 2022/07/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lansoprazole For Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20100066 | 2022/03/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 注射用盐酸头孢吡肟 · No verified English name | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20060426 | 2022/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 注射用盐酸头孢吡肟 · No verified English name | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20050360 | 2022/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20043001 | 2021/12/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20043014 | 2021/12/03 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20067963 | 2021/12/03 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Omeprazole Enteric Capsules | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20056577 | 2021/11/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metformin Hydrochloride Tablets | Youcare Pharmaceutical Group Co., Ltd. | Youcare Pharmaceutical Group Co., Ltd. | 国药准字H20184075 | 2020/12/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
5 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Indocyaninegreen for Injection | CYHS2403430 | Generic | 2024/10/13 | Beijing Shu Zi Jing Zhun Medical Technology Co., Ltd. romanized; Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 甲磺酸双氢麦角毒碱片 · No verified English name | CYHB2302275 | Supplement | 2023/10/13 | 北京博喆研医药科技有限公司; Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Piperacillin Sodium for Injection | CYHS2201852 | Generic | 2022/10/29 | Shanxi Ming Yu Bio Technology Co., Ltd. romanized; Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Doxofylline Injection | CYHS2201234 | Generic | 2022/08/04 | Ge Lin Fei Er De (Jiangsu) Pharma Co., Ltd. romanized; Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 丙戊酸钠 · No verified English name | JTH2200084 | Not stated by source | 2022/04/26 | Sun Pharmaceutical Industries Ltd.; Youcare Pharmaceutical Group Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/20
- Chemical-drug catalogue
- Last successful update: 2026/11/20
- API registrations
- Last successful update: 2026/11/20
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.